Hernández-Preciado, M.R.; Marquez-Pedroza, J.; Sánchez-Rosales, N.A.; GarcÃa-Rivera, J.d.J.; Kobayashi-Gutiérrez, A.; Torres-Mendoza, B.M.; ChavarrÃa-Avila, E.; Montaño-Serrano, R.A.; Cortes-Enriquez, F.; Mireles-RamÃrez, M.A.
Effect of Rituximab Compared with Natalizumab and Fingolimod in Patients with Relapsing–Remitting Multiple Sclerosis: A Cohort Study. J. Clin. Med. 2022, 11, 3584.
https://doi.org/10.3390/jcm11133584
AMA Style
Hernández-Preciado MR, Marquez-Pedroza J, Sánchez-Rosales NA, GarcÃa-Rivera JdJ, Kobayashi-Gutiérrez A, Torres-Mendoza BM, ChavarrÃa-Avila E, Montaño-Serrano RA, Cortes-Enriquez F, Mireles-RamÃrez MA.
Effect of Rituximab Compared with Natalizumab and Fingolimod in Patients with Relapsing–Remitting Multiple Sclerosis: A Cohort Study. Journal of Clinical Medicine. 2022; 11(13):3584.
https://doi.org/10.3390/jcm11133584
Chicago/Turabian Style
Hernández-Preciado, Martha Rocio, Jazmin Marquez-Pedroza, Nayeli Alejandra Sánchez-Rosales, José de Jesús GarcÃa-Rivera, Antonio Kobayashi-Gutiérrez, Blanca Miriam Torres-Mendoza, EfraÃn ChavarrÃa-Avila, Raúl Alejandro Montaño-Serrano, Fernando Cortes-Enriquez, and Mario Alberto Mireles-RamÃrez.
2022. "Effect of Rituximab Compared with Natalizumab and Fingolimod in Patients with Relapsing–Remitting Multiple Sclerosis: A Cohort Study" Journal of Clinical Medicine 11, no. 13: 3584.
https://doi.org/10.3390/jcm11133584
APA Style
Hernández-Preciado, M. R., Marquez-Pedroza, J., Sánchez-Rosales, N. A., GarcÃa-Rivera, J. d. J., Kobayashi-Gutiérrez, A., Torres-Mendoza, B. M., ChavarrÃa-Avila, E., Montaño-Serrano, R. A., Cortes-Enriquez, F., & Mireles-RamÃrez, M. A.
(2022). Effect of Rituximab Compared with Natalizumab and Fingolimod in Patients with Relapsing–Remitting Multiple Sclerosis: A Cohort Study. Journal of Clinical Medicine, 11(13), 3584.
https://doi.org/10.3390/jcm11133584
